Yantai Dongcheng Pharmaceutical Group Co.,Ltd.

XSEC:002675 Voorraadrapport

Marktkapitalisatie: CN¥10.7b

Yantai Dongcheng Pharmaceutical GroupLtd Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Yantai Dongcheng Pharmaceutical GroupLtd has a total shareholder equity of CN¥5.5B and total debt of CN¥839.7M, which brings its debt-to-equity ratio to 15.4%. Its total assets and total liabilities are CN¥8.6B and CN¥3.2B respectively. Yantai Dongcheng Pharmaceutical GroupLtd's EBIT is CN¥233.6M making its interest coverage ratio 3.2. It has cash and short-term investments of CN¥955.2M.

Belangrijke informatie

15.4%

Verhouding schuld/eigen vermogen

CN¥839.75m

Schuld

Rente dekkingsratio3.2x
ContantCN¥955.20m
AandelenCN¥5.47b
Totaal verplichtingenCN¥3.17b
Totaal activaCN¥8.64b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Analyse van de financiële positie

Kortlopende schulden: 002675's short term assets (CN¥2.6B) exceed its short term liabilities (CN¥1.7B).

Langlopende schulden: 002675's short term assets (CN¥2.6B) exceed its long term liabilities (CN¥1.5B).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 002675 has more cash than its total debt.

Schuld verminderen: 002675's debt to equity ratio has reduced from 17.8% to 15.4% over the past 5 years.

Schuldendekking: 002675's debt is well covered by operating cash flow (43.1%).

Rentedekking: 002675's interest payments on its debt are well covered by EBIT (3.2x coverage).


Balans


Ontdek gezonde bedrijven